Oral SERD Impresses in Advanced Breast Cancer With ESR1 Mutations

(MedPage Today) -- SAN ANTONIO -- Among patients with estrogen receptor (ER)-positive, HER2-negative advanced breast cancer, treatment with imlunestrant did not significantly improve progression-free survival (PFS) compared with standard endocrine...